Bioreactors as engineering support to treat cardiac muscle and vascular disease

Journal of Healthcare Engineering

Volumn 4, Issue 3, 2013, Pages 329-370

  Massai, Diana ^a   Cerino, Giulia ^a   Gallo, Diego ^a   Pennella, Francesco ^a   Deriu, Marco A ^a   Rodriguez, Andres ^a   Montevecchi, Franco M ^a   Bignardi, Cristina ^a   Audenino, Alberto ^a   Morbiducci, Umberto ^a  

^a POLITECNICO DI TORINO   (Italy)

Author keywords

Bioreactor; Blood vessels; Cardiovascular tissue engineering; Heart; Physiological stimuli

Indexed keywords

BIOCONVERSION; BIOREACTORS; BLOOD VESSELS; HEART; PHYSIOLOGY; TISSUE ENGINEERING;

CARDIO-VASCULAR DISEASE; CARDIOVASCULAR TISSUE ENGINEERING; CARDIOVASCULAR TISSUES; CULTURE ENVIRONMENTS; DYNAMIC ENVIRONMENTS; ENGINEERING SUPPORT; MONITORING AND CONTROLLING; PHYSIOLOGICAL STIMULI;

TISSUE;

BIOREACTOR; BLOOD VESSEL; CARDIOVASCULAR DISEASE; HEART; HEART MUSCLE; HUMAN; REVIEW; TISSUE ENGINEERING; VASCULAR DISEASE; VASCULAR TISSUE; ANIMAL; BIOMEDICAL ENGINEERING; EQUIPMENT; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HEART DISEASE; HEART MUSCLE CELL; ORGAN CULTURE TECHNIQUE; PATHOLOGY; TRANSPLANTATION;

ANIMALS; BIOMEDICAL ENGINEERING; BIOREACTORS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; TISSUE ENGINEERING; VASCULAR DISEASES;

EID: 84885660112     PISSN: 20402295     EISSN: 20402309     Source Type: Journal    
DOI: 10.1260/2040-2295.4.3.329     Document Type: Review

References (143)

1. Roger VL, Go AS Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 2012, 125(1):188-197.
2. Ptaszek LM, Mansour M, Ruskin J.N., Chien KR Towards regenerative therapy for cardiac disease. Lancet, 2012, 379(9819):933-942.
3. World Health Organization - WHO. Fact Sheet No 317, Cardiovascular diseases. Geneva, Switzerland. September 2011. http://www.who.int/en/. Accessed July 12, 2012.
4. Leor J, Amsalem Y, Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacology and Therapeutics, 2005, 105(2):151-163.
5. Eschenhagen T, Didié M, Münzel F, Schubert P, Schneiderbanger K, Zimmermann WH. 3D engineered heart tissue for replacement therapy. Basic Research in Cardiology, 2002, 97(SUPPL. 1):146-152.
6. Jawad H, Lyon AR, Harding S.E., Ali NN, Boccaccini AR Myocardial tissue engineering. British Medical Bulletin, 2008, 87:31-47.
7. Akins RE, Boyce RA, Madonna M.L., Schroedl NA, Gonda SR, McLaughlin TA, Hartzell CR Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Engineering, 1999, 5(2):103-118.
8. Jawad H, Ali NN, Lyon A.R., Chen QZ, Harding SE, Boccaccini AR Myocardial tissue engineering: a review. Journal of Tissue Engineering and Regenerative Medicine, 2007, 1(5):327-342.
9. Vunjak-Novakovic G., Tandon N, Godier A., Maidhof R, Marsano A, Martens T.P., Radisic M. Challenges in cardiac tissue engineering. Tissue Engineering Part B Review, 2010, 16(2):169-187.
10. Strüber M., Meyer AL, Malehsa D, Kugler C., Simon AR, Haverich A. The current status of heart transplantation and the development of "artificial heart systems,". Deutsches Ärzteblatt International, 2009, 106(28-29):471-477.
11. Eagle KA, Guyton RA, Davidoff R, Edwards F.H., Ewy GA, Gardner TJ, Hart JC, Herrmann H.C., Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation, 2004, 110(14):340-437.
12. Gauvin R, Guillemette M, Galbraith T., Bourget JM, Larouche D, Marcoux H, Aubé D, Hayward C, Auger FA, Germain L. Mechanical properties of tissue-engineered vascular constructs produced using arterial or venous cells. Tissue Engineering Part A, 2011, 17(15-16):2049-2059.
13. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. Stenting versus endarterectomy for treatment of carotid-artery stenosis. The New England Journal of Medicine, 2010, 363(1):11-23.
14. Chlupác J., Filová E, Bacáková L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiological Research, 2009, 58(SUPPL. 2):S119-139.
15. Karam JP, Muscari C, Montero-Menei CN. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials, 2012, 33(23):5683-5695.
16. Slaughter MS, Rogers JG, Milano C.A., Russell SD, Conte J V, Feldman D, Sun B., Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. The New England Journal of Medicine, 2009, 361(23):2241-2251.
17. Oz MC, Argenziano M, Catanese K.A., Gardocki MT, Goldstein DJ, Ashton RC, Gelijns A.C., Rose EA, Levin HR Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation, 1997, 95(7):1844-1852.
18. Matsumura G, Hibino N, Ikada Y., Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials, 2003, 24(13):2303-2308.
19. Hassink RJ, Dowell JD, Brutel de la Rivière A, Doevendans PA, Field LJ. Stem cell therapy for ischemic heart disease. Trends in Molecular Medicine, 2003, 9(10):436-441.
20. Hassink RJ, Brutel de la Rivière A, Mummery CL, Doevendans PA. Transplantation of cells for cardiac repair. Journal of the American College of Cardiology, 2003, 41(5):711-717.
21. Orlic D, Kajstura J, Chimenti S., Limana F, Jakoniuk I, Quaini F., Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Protocol of the National Academy of Science of the United States of America, 2001, 98(18):10344-10349.
22. Pasumarthi KB, Field LJ Cardiomyocyte cell cycle regulation. Circulation Research, 2002, 90(10):1044-1054.
23. Field LJ. Modulation of the cardiomyocyte cell cycle in genetically altered animals. Annals of the New York Academy of Science, 2004, 1015:160-170.
24. Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M., Soonpaa MH, Brutel de la Rivière A, Doevendans PA, Field LJ. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovascular Research, 2008, 78(1):18-25.
25. Porrello ER, Mahmoud AI, Simpson E, Hill J.A., Richardson JA, Olson EN, Sadek HA Transient regenerative potential of the neonatal mouse heart. Science, 2011, 331(6020):1078-1080.
26. Kikuchi K, Holdway JE, Werdich A.A., Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae C.A., Stainier D Y, Poss D. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature, 2010, 464(7288):601-605.
27. Bilodeau K, Mantovani D. Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Engineering, 2006, 12(8):2367-2383.
28. Lyons F, Partap S, O?Brien FJ. Part 1: scaffolds and surfaces. Technology and Healthcare, 2008, 16(4):305-317.
29. Grayson WL, Martens TP, Eng G.M., Radisic M., Vunjak-Novakovic G. Biomimetic approach to tissue engineering. Seminars in cells and developmental biology, 2009, 20(6):665-673.
30. Egli RJ, Luginbuehl R. Tissue engineering - nanomaterials in the musculoskeletal system. Swiss Medical Weekly, 2012, 142:w13647.
31. Figallo E. Advanced technologies for cardiac tissue engineering. PhD Dissertation, Università degli Studi di Padova, 2008.
32. Ogawa R, Oki K, Hyakusoku H. Vascular tissue engineering and vascularized 3D tissue regeneration. Regenerative Medicine, 2007, 2(5):831-837.
33. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnology, 2004, 22(2):80-86.
34. Plunkett N, O'Brien FJ. Bioreactors in tissue engineering. Studies in Health Technology and Information, 2010, 152:214-230.
35. Carrier RL, Papadaki M, Rupnick M., Schoen FJ, Bursac N, Langer R, Freed L.E., Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnology and Bioengineering, 1999, 64(5):580-589.
36. Carrier R. Cardiac tissue engineering: bioreactor cultivation parameters. PhD Dissertation, Massachusetts Institute of Technology, 2000.
37. Korossis SA, Bolland F, Kearney J.N., Fisher J., Ingham E. Bioreactors in tissue engineering, in: Nureddin Ashammakhi, Rui L Reis (eds). Topics in Tissue Engineering, Volume 2, 2005, Chapter 8.
38. Dumont K, Yperman J, Verbeken E., Segers P, Meuris B, Vandenberghe S., Flament W, Verdonk PR Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artificial Organs, 2002, 26(8):710-714.
39. Martin I, Smith T, Wendt D. Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnology, 2009, 27(9):495-502.
40. Archer R, Williams DJ Why tissue engineering needs process engineering. Nature Biotechnology, 2005, 23(11):1353-1355.
41. Pörtner R., Nagel-Heyer S, Goepfert C., Adamietz P, Meenen NM Bioreactor design for tissue engineering. Journal for Bioscience and Bioengineering, 2005, 100(3):235-245.
42. Olmer R, Lange A, Selzer S., Kasper C, Haverich A, Martin U., Zweigerdt R. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Engineering Part C Methods, 2012, 18(10):772-784.
43. Bouten CV, Dankers PY, Driessen-Mol A, Pedron S., Brizard AM, Baaijens FP Substrates for cardiovascular tissue engineering. Advanced Drug Delivery Reviews, 2011, 63(4-5):221-241.
44. Shachar M, Cohen S. Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Failure Reviews, 2003, 8(3):271-276.
45. Ratcliffe A, Niklason LE Bioreactors and bioprocessing for tissue engineering. Annals of the NY Academy of Sciences, 2002, 96:210-215.
46. Sen A, Kallos MS, Behie LA New tissue dissociation protocol for scaled-up production of neural stem cells in suspension bioreactors. Tissue Engineering, 2004, 10(5-6):904-913.
47. Schaaf S, Shibamiya A, Mewe M., Eder A, Stöhr A, Hirt M.N., Rau T., Zimmermann WH, Conradi L, Eschenhagen T. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One, 2011, 6(10):e26397.
48. Irani K, Pomerantseva I, Hart A.R., Sundback CA, Neville CM, Vacanti JP Mechanical dissociation of swine liver to produce organoid units for tissue engineering and in vitro disease modeling. Artificial Organs, 2010, 34(1):75-78.
49. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man anatomic validation of the method. Circulation, 1977, 55(4):613-618.
50. Schneck D. An outline of cardiovascular structure and function, in: Bernhard Palsson, Jeffrey A. Hubbell, Robert Plonsey, Joseph D. Bronzino (eds). Tissue Engineering, CRC Press, 2003, I-1-I-12.
51. Fortuin NJ, Hood WP Jr, Sherman ME, Craige E. Determination of left ventricular volumes by ultrasound. Circulation, 1971, 44:575-584.
52. Mahoney LT, Smith W, Noel M.P., Florentine M., Skorton DJ, Collins SM Measurement of right ventricular Volume using cine computer tomography. Investigative Radiology, 1987, 22(6):451-455.
53. Klingensmith ME, Ern Chen L, Glasgow SC, Goers T.A., Melby SJ The Washington Manual of Surgery. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.
54. Punchard MA, Stenson-Cox C, O'cearbhaill ED, Lyons E, Gundy S., Murphy L, Pandit A, McHugh P.E., Barron V. Endothelial cell response to biomechanical forces under simulated vascular loading conditions. Journal of Biomechanics, 2007, 40(14):3146-3154.
55. Konig G, McAllister TN, Dusserre N, Garrido S.A., Iyican C., Marini A, Fiorillo A, Wystrychowski W., Zagalski K, Maruszewski M, Jones A.L., Cierpka L., de la Fuente LM, L'Heureux N. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials, 2009, 30(8):1542-1550.
56. Mayrovitz HN, Tuma RF, Wiedeman MP Relationship between microvascular blood velocity and pressure distribution. American Journal of Physiology, 1977, 232(4):400-405.
57. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. The Journal of the American Medical Association, 1999, 282(21):2035-2042.
58. Kuznetsova T, Herbots L, Richart T., D?hooge J, Thijs L, Fagard RH, Herregods MC, Staessen JA. Left ventricular strain and strain rate in a general population. European Heart Journal, 2008, 29(16):2014-2023.
59. Mironov V, Kasyanov V, McAllister K., Oliver S, Sistino J, Markwald R. Perfusion bioreactor for vascular tissue engineering with capacities for longitudinal stretch. Journal of Craniofacial Surgery, 2003, 14(3):340-347.
60. Tandon N, Cannizzaro C, Chao P.G., Maidhof R., Marsano A, Au HT, Radisic M, Vunjak-Novakovic G. Electrical stimulation systems for cardiac tissue engineering. Nature Protocols, 2009, 4(2):155-173.
61. Buckberg GD. Basic science review: the helix and the heart. Journal of Thoracic and Cardiovascular Surgery, 2002, 124(5):863-883.
62. Akhyari P, Kamiya H, Haverich A., Karck M, Lichtenberg A. Myocardial tissue engineering: the extracellular matrix. European Journal of Cardiothoracic Surgery, 2008, 34(2):229-241.
63. Carrier RL, Rupnick M, Langer R., Schoen FJ, Freed LE, Vunjak-Novakovic G. Effects of oxygen on engineered cardiac muscle. Biotechnology Bioengineering, 2002, 78(6):617-625.
64. Holubarsch C, Ludemann J, Wiessner S., Ruf T, Schulte-Baukloh H, Schmidt-Schweda S, Pieske B., Posival H, Just H. Shortening versus isometric contractions in isolated human failing and non-failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation. Cardiovascular Research, 1998, 37(1):46-57.
65. Mulieri LA, Hasenfuss G, Leavitt B., Allen PD, Alpert NR Altered myocardial force-frequency relation in human heart failure. Circulation, 1992, 85(5):1743-1750.
66. Durand DM. Electrical stimulation of excitable tissue, in: Joseph D Bronzino (ed). The Biomedical Engineering Handbook, 2nd ed., CRC Press, 2000, Chapter 17.
67. Nuccitelli R. Endogenous ionic currents and DC electric fields in multicellular animal tissues. Bioelectromagnetics, 1992, Suppl 1:147-157.
68. Zimmermann WH, Fink C, Kralisch D., Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnology and Bioengineering, 2000, 68(1):106-114.
69. Zimmermann WH, Melnychenko I, Wasmeier G., Didié M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine, 2006, 12(4):452-458.
70. Smotherman WP, Robinson SR, Ronca A.E., Alberts JR, Hepper PG Heart rate response of the rat fetus and neonate to a chemosensory stimulus. Physiology & Behaviour, 1991, 50(1):47-52.
71. WikiVet. http://en.wikivet.net/Rat-Physiology-WikiNormals. Accessed January 2, 2013.
72. Mun CH, Jung Y, Kim S.H., Lee SH, Kim HC, Kwon IK, Kim SH Three-dimensional electrospun poly(lactide-co-ε-caprolactone) for small-diameter vascular grafts. Tissue Engineering Part A, 2012, 18(15-16):1608-1616.
73. Shadwick RE. Mechanical design in arteries. The Journal of Experimental Biology, 1999, 202:3305-3313.
74. Learoyd BM, Taylor MG Alterations with age in the viscoelastic properties of human arterial walls. Circulation Research, 1966, 18:278-292.
75. Adams D, McKinley M. The sheep. Anzccart Human Science. Fact Sheet A9. July, 2009. http://www.adelaide.edu.au/ANZCCART/publications/A9-SheepFactSheet. pdf. Accessed January 3, 2013.
76. Esposito F, Vitale N, Crescenzi B., Scardone M, de Luca L, Cotrufo M. Short-term results of bovine internal mammary artery use in cardiovascular surgery. Texas Heart Institute Journal, 1994, 21(3):193-197.
77. WIkiVet. http://en.wikivet.net/Bovine-Physiology-WikiNormals. Accessed January 2, 2013.
78. Doyle JT, Patterson JL Jr, Warren JV, Detweiler DK Observations on the circulation of domestic cattle. Circulation Research, 1960, 8:4-15.
79. Rashid ST, Salacinski HJ, Hamilton G, Seifalian AM The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials, 2004, 25(9):1627-1637.
80. Fink C, Ergün S, Kralisch D., Remmers U, Weil J, Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Federation of American Societies for Experimental Biology Journal, 2000, 14(5):669-679.
81. Wendt D, Riboldi SA, Cioffi M, Martin I. Potential and bottlenecks of bioreactors in 3D cell culture and tissue manufacturing. Advanced Materials, 2009, 21(32-33):3352-3367.
82. Freed LE, Guilak F, Guo X.E., Gray ML, Tranquillo R, Holmes JW, Radisic M, Sefton M V, Kaplan D, Vunjak-Novakovic G. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Engineering, 2006, 12(12):3285-3305.
83. Barron V, Lyons E, Stenson-Cox C, McHugh P.E., Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Annals of Biomedical Engineering, 2003, 31(9):1017-1030.
84. Nasseri BA, Pomerantseva I, Kaazempur-Mofrad MR, Sutherland F.W., Perry T., Ochoa E, Thompson CA, Mayer JE Jr, Oesterle SN, Vacanti JP Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Engineering, 2003, 9(2):291-299.
85. Tandon N, Marsano A, Cannizzaro C., Voldman J, Vunjak-Novakovic G. Design of electrical stimulation bioreactors for cardiac tissue engineering. Conference Proceedings - IEEE Engineering in Medicine and Biology Society, 2008, 3594-3597.
86. Mertsching H, Hansmann J. Bioreactor technology in cardiovascular tissue engineering. Advances in Biochemical Engineering Biotechnology, 2009, 112:29-37.
87. Gonen-Wadmany M., Gepstein L, Seliktar D. Controlling the cellular organization of tissue-engineered cardiac constructs. Annals of the NY Academy of Sciences, 2004, 1015:299-311.
88. Lyons E, Pandit A. Design of bioreactors for cardiovascular applications, in: Nureddin Ashammakhi, Rui L Reis (eds). Topics in Tissue Engineering, Volume 2, 2005, Chapter 7.
89. Papadaki M, Bursac N, Langer R., Merok J, Vunjak-Novakovic G, Freed LE Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. American Journal of Physiology Heart and Circulatory Physiology, 2001, 280(1):168-178.
90. Eschenhagen T, Fink C, Remmers U., Schols H, Wattchow J, Weil J., Zimmermann W, Dohmen HH, Schäfer H, Bishopric N., Wakatsuki T, Elson EL Three dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Federation of American Societies for Experimental Biology Journal, 1997, 11:683-694.
91. Zimmermann WH, Schneiderbanger K, Schubert P., Didié M, Münzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T. Tissue engineering of a differentiated cardiac muscle construct. Circulation Research, 2002, 90(2):223-230.
92. Birla RK, Huang YC, Dennis RG Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Engineering, 2007, 13(9):2239-2248.
93. Akins RE, Boyce RA, Madonna M.L., Schroedl NA, Gonda SR, McLaughlin TA, Hartzell CR Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Engineering, 1999, 5(2):103-118.
94. Carrier RL, Rupnick M, Langer R., Schoen F, Freed LE, Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Engineering, 2002, 8(2):175-188.
95. Radisic M, Euloth M, Yang L., Langer R, Freed LE, Vunjak-Novakovic G. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnology Bioengineering, 2003, 82(4):403-414.
96. Radisic M, Park H, Shing H., Consi T, Schoen FJ, Langer R, Freed L.E., Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proceedings of the National Academy of Science of the USA, 2004, 101(52):18129-18134.
97. Tandon N, Marsano A, Maidhof R., Wan L, Park H, Vunjak-Novakovic G. Optimization of electrical stimulation parameters for cardiac tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 2011, 5(6):115-125.
98. Tandon N, Goh B, Marsano A., Chao PH, Montouri-Sorrentino C, Gimble J, Vunjak-Novakovic G. Alignment and elongation of human adipose-derived stem cells in response to direct-current electrical stimulation. Conference Proceedings - IEEE Engineering in Medicine and Biology Society, 2009, 6517-6521.
99. Barash Y, Dvir T, Tandeitnik P., Ruvinov E, Guterman H, Cohen S. Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Engineering Part C Methods, 2010, 16(6):1417-1426
100. Maidhof R, Tandon N, Lee E.J., Luo J., Duan Y, Yeager K, Konofagou E., Vunjak-Novakovic G. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. Journal of Tissue Engineering and Regenerative Medicine, 2012, 6(10):e12-23.
101. Hansen A, Eder A, Bönstrup M, Flato M., Mewe M, Schaaf S, Aksehirlioglu B., Schwörer A, Uebeler J., Eschenhagen T. Development of a Drug Screening Platform Based on Engineered Heart Tissue. Circulation Research, 2010, 107:35-44.
102. Kensah G, Gruh I, Viering J., Schumann H, Dahlmann J, Meyer H., Skvorc D, Bär A, Akhyari P., Heisterkamp A, Haverich A, Martin U. A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Engineering Part C Methods, 2011, 17(4):463-473.
103. Kensah G, Roa Lara A, Dahlmann J, Zweigerdt R., Schwanke K, Hegermann J, Skvorc D., Gawol A, Azizian A, Wagner S., Maier LS, Krause A, Dräger G, Ochs M., Haverich A, Gruh I, Martin U. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. European Heart Journal, 2012.
104. Boudou T, Legant WR, Mu A, Borochin M.A., Thavandiran N., Radisic M, Zandstra PW, Epstein J.A., Margulies KB, Chen CS A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Engineering Part A, 2012, 18(9-10):910-919.
105. Eschenhagen T, Didié M, Heubach J, Ravens U, Zimmerman WH. Cardiac tissue engineering. Transplant Immunology, 2002, 9(2-4):315-321.
106. Zimmermann WH, Didié M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, Eschenhagen T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation, 2002, 106(12 Suppl 1):151-157.
107. Bursac N, Papadaki M, Cohen R.J., Schoen FJ, Eisenberg SR, Carrier R, Vunjak-Novakovic G, Freed LE Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. American Journal of Physiology, 1999, 277(2 Pt 2):H433-44.
108. Radisic M, Marsano A, Maidhof R., Wang Y, Vunjak-Novakovic G. Cardiac tissue engineering using perfusion bioreactor systems. Nature Protocols, 2008, 3(4):719-738.
109. Dvir T, Levy O, Shachar M., Granot Y, Cohen S. Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Engineering, 2007, 13(9):2185-2193.
110. Brown MA, Iyer RK, Radisic M. Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnology Progress, 2008, 24(4):907-920.
111. Holubarsch C, Ludemann J, Wiessner S., Ruf T, Schulte-Baukloh H, Schmidt-Schweda S, Pieske B., Posival H, Just H. Shortening versus isometric contractions in isolated human failing and non-failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation. Cardiovascular Research, 1998, 37:46-57.
112. Mulieri LA, Hasenfuss G, Leavitt B., Allen PD, Alpert NR Altered myocardial force-frequency relation in human heart failure. Circulation, 1992, 85:1743-1750.
113. Dahlmann J, Krause A, Möller L, Kensah G., Möwes M, Diekmann A., Martin U, Kirschning A, Gruh I., Dräger G. Fully defined in situ cross-linkable alginate and hyaluronic acid hydrogels for myocardial tissue engineering. Biomaterials, 2013, 34(4):940-951.
114. Hoerstrup SP, Zünd G, Sodian R., Schnell AM, Grünenfelder J, Turina MI Tissue engineering of small caliber vascular grafts. European Journal of Cardiothoracic Surgery, 2001, 20(1):164-169
115. Song H, Zandstra PW, Radisic M. Engineered heart tissue model of diabetic myocardium. Tissue Engineering Part A, 2011, 17(13-14):1869-1878.
116. Krawiec JT, Vorp DA Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials, 2012, 33(12):3388-3400.
117. Sheridan WS, Duffy JP, Murphy BP Mechanical characterization of a customized decellularized scaffold for vascular tissue engineering. Journal of the Mechanical Behavior of Biomedical Materials, 2012, 8:58-70.
118. Iwasaki K, Kojima K, Kodama S., Paz AC, Chambers M, Umezu M, Vacanti CA Bioengineered three-layered robust and elastic artery using hemodynamically- equivalent pulsatile bioreactor. Circulation, 2008, 118(SUPPL. 14):S52-S57.
119. Cleary MA, Geiger E, Grady C., Best C, Naito Y, Breuer C. Vascular tissue engineering: the next generation. Trends in Molecular Medicine, 2012, 18(7):394-404.
120. Niklason LE, Gao L, Abbott W.M., Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science, 1999, 284(5413):489-493.
121. Teebken OE, Haverich A. Tissue engineering of small-diameter vascular grafts. European Journal of Vascular and Endovascular Surgery, 2002, 23:475:485.
122. Yap LH, Butler CE Principles of Microsurgery, in: Charles H Thorne (ed). Grabb and Smith's Plastic Surgery, 6th ed., Wolters Kluwer Health/Lippincott Williams & Wilkins, 2006, 66-72.
123. Zhao T, Zhao W, Chen Y., Ahokas RA, Sun Y. Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvascular Research, 2010, 80(2):188-194.
124. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science, 1986, 231:397-400.
125. L'Heureux N., Pâquet S, Labbé R, Germain L, Auger F. A completely biological tissue-engineered human blood vessel. Federation of American Societies for Experimental Biology Journal, 1998, 12(1):47-56.
126. Geeslin MG, Caron GJ, Kren S.M., Sparrow EM, Hultman DA, Taylor DA Bioreactor for the reconstitution of a decellularized vascular matrix of biological origin. Journal of Biomedical Science and Engineering, 2011, 4:435-442.
127. Williams C, Wick TM Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Engineering, 2004, 10(5-6):930-941.
128. Narita Y, Hata K, Kagami H., Usui A, Ueda M, Ueda Y. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Engineering, 2004, 10(7-8):1224-1233.
129. Yazdani SK, Watts B, Machingal M., Jarajapu YP, Van Dyke ME, Christ GJ Smooth muscle cell seeding of decellularized scaffolds: the importance of bioreactor preconditioning to development of a more native architecture for tissue-engineered blood vessels. Tissue Engineering Part A, 2009, 15(4):827-840.
130. Bilodeau K, Couet F, Boccafoschi F., Mantovani D. Design of a perfusion bioreactor specific to the regeneration of vascular tissues under mechanical stresses. Artificial Organs, 2005, 29(11):906-912.
131. Zhang X, Wang X, Keshav V., Wang X, Johanas JT, Leisk G.G., Kaplan DL Dynamic culture conditions to generate silk-based tissue-engineered vascular grafts. Biomaterials, 2009, 30(19):3213-3223.
132. Amensag S, McFetridge PS Rolling the human amnion to engineer laminated vascular tissues. Tissue Engineering Part C Methods, 2012, 18(11):903-912.
133. Couet F, Meghezi S, Mantovani D. Fetal development, mechanobiology and optimal control processes can improve vascular tissue regeneration in bioreactors: an integrative review. Medical Engineering and Physics, 2012, 34(3):269-278.
134. Maidhof R, Marsano A, Lee E.J., Vunjak-Novakovic G. Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnology Progress, 2010, 26(2):565-572.
135. Lovett M, Rockwood D, Baryshyan A., Kaplan DL Simple modular bioreactors for tissue engineering: a system for characterization of oxygen gradients, human mesenchymal stem cell differentiation, and prevascularization. Tissue Engineering Part C Methods, 2010, 16(6):1565-1573.
136. Paten JA, Zareian R, Saeidi N., Melotti SA, Ruberti JW Design and performance of an optically accessible, low-volume, mechanobioreactor for long-term study of living constructs. Tissue Engineering Part C Methods, 2011, 17(7):775-788.
137. Loverde RJ, Tolentino RE, Pfister BJ Axon stretch growth: the mechanotransduction of neuronal growth. Journal of Visualized Experiments, 2011, (54):2753.
138. Mortati L, Divieto C, Sassi MP CARS and SHG microscopy to follow collagen production in living human corneal fibroblasts and mesenchymal stem cells in fibrin hydrogel 3D cultures. Journal of Raman Spectroscopy, 2012, 43:675-680.
139. Consolo F, Bariani C, Mantalaris A., Montevecchi FM, Redaelli A, Morbiducci U. Computational modeling for the optimization of a cardiogenic 3D bioprocess of encapsulated embryonic stem cells. Biomechanics and Modeling in Mechanobiology, 2012, 11(1-2):261-277.
140. Hidalgo-Bastida L.A., Thirunavukkarasu S, Griffiths S., Cartmell SH, Naire S. Modeling and design of optimal flow perfusion bioreactors for tissue engineering applications. Biotechnology and Bioengineering, 2012, 109(4):1095-1099.
141. Israelowitz M, Weyand B, Rizvi S., Vogt PM, von Schroeder HP. Development of a laminar flow bioreactor by computational fluid dynamics. Journal of Healthcare Engineering, 2012, 3(3):455-476.
142. Couet F, Mantovani D. Optimization of culture conditions in a bioreactor for vascular tissue engineering using a mathematical model of vascular growth and remodeling. Cardiovascular Engineering and Technology, 2012, 3(2):228-236.
143. Figallo E, Cannizzaro C, Gerecht S., Burdick JA, Langer R, Elvassore N, Vunjak-Novakovic G. Micro-bioreactor array for controlling cellular microenvironments. Lab on a Chip, 2007, 7(6):710-719.